Publications by authors named "Stephanie Stringer"

Claim this Profile
O
Optimizing autologous stem cell collections for patients with multiple myeloma receiving G-CSF and Plerixafor: A single center project.
Ayda Javanbakht, Stephanie Stringer, Hollie Anderson, Ellie Hamilton, Anisha Philip

J Clin Apher· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is there a role of the kidney failure risk equation in optimizing timing of vascular access creation in pre-dialysis patients?
Külli Kuningas, Stephanie Stringer, Paul Cockwell, Aurangzaib Khawaja, Nicholas Inston

J Vasc Access· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors associated with COVID-19 severity among patients on maintenance haemodialysis: a retrospective multicentre cross-sectional study in the UK.
Haresh Selvaskandan, Katherine L Hull, Sherna Adenwalla, Safa Ahmed, Maria-Cristina Cusu, Stephanie Stringer

BMJ Open· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of a pilot feasibility randomised controlled trial exploring the use of an electronic patient-reported outcome measure in the management of UK patients with advanced chronic kidney disease.
Derek Kyte, Nicola Anderson, Jon Bishop, Andrew Bissell, Elizabeth Brettell, Stephanie Stringer

BMJ Open· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an electronic patient-reported outcome measure (ePROM) system to aid the management of patients with advanced chronic kidney disease.
Derek Kyte, Nicola Anderson, Ram Auti, Olalekan Lee Aiyegbusi, Jon Bishop, Stephanie Stringer

J Patient Rep Outcomes· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of an electronic patient-reported outcome measure in the management of patients with advanced chronic kidney disease: the RePROM pilot trial protocol.
Derek Kyte, Jon Bishop, Elizabeth Brettell, Melanie Calvert, Paul Cockwell, Stephanie Stringer

BMJ Open· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease.
Anthony Fenton, Mark D Jesky, Rachel Webster, Stephanie J Stringer, Punit Yadav

PLoS One· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arterial stiffness alone does not explain arteriovenous fistula outcomes.
Damian G McGrogan, Stephanie Stringer, Paul Cockwell, Mark Jesky, Charlie Ferro

J Vasc Access· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-Related Quality of Life Impacts Mortality but Not Progression to End-Stage Renal Disease in Pre-Dialysis Chronic Kidney Disease: A Prospective Observational Study.
Mark D Jesky, Mary Dutton, Indranil Dasgupta, Punit Yadav, Khai Ping Ng, Stephanie J Stringer

PLoS One· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caveolin-1 single-nucleotide polymorphism and arterial stiffness in non-dialysis chronic kidney disease.
Sourabh Chand, Nicola C Edwards, Colin D Chue, Mark Jesky, Stephanie Stringer

Nephrol Dial Transplant· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with multiple myeloma have excellent long-term outcomes after recovery from dialysis-dependent acute kidney injury.
Punit Yadav, Colin A Hutchison, Kolitha Basnayake, Stephanie Stringer, Mark Jesky

Eur J Haematol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum tryptase concentration and progression to end-stage renal disease.
Mark D Jesky, Stephanie J Stringer, Anthony Fenton, Khai Ping Ng, Punit Yadav

Eur J Clin Invest· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allopurinol is an independent determinant of improved arterial stiffness in chronic kidney disease: a cross-sectional study.
Khai P Ng, Stephanie J Stringer, Mark D Jesky, Punit Yadav, Rajbir Athwal

PLoS One· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The periodontal health component of the Renal Impairment In Secondary Care (RIISC) cohort study: a description of the rationale, methodology and initial baseline results.
Praveen Sharma, Thomas Dietrich, Amneet Sidhu, Viren Vithlani, Mutahir Rahman, Stephanie Stringer

J Clin Periodontol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum polyclonal immunoglobulin free light chain levels predict mortality in people with chronic kidney disease.
Colin A Hutchison, Anne Burmeister, Stephen J Harding, Kolitha Basnayake, Hannah Church, Stephanie J Stringer

Mayo Clin Proc· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimising the accuracy of blood pressure monitoring in chronic kidney disease: the utility of BpTRU.
Shona Brothwell, Mary Dutton, Charles Ferro, Stephanie Stringer, Paul Cockwell

BMC Nephrol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The natural history of, and risk factors for, progressive chronic kidney disease (CKD): the Renal Impairment in Secondary care (RIISC) study; rationale and protocol.
Stephanie Stringer, Praveen Sharma, Mary Dutton, Mark Jesky, Khai Ng

BMC Nephrol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Achieving an early myeloma response in patients with kidney impairment.
Stephanie Stringer, Mark Cook, Paul Cockwell

Adv Chronic Kidney Dis· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Why did I start dialysis? A qualitative study on views and expectations from an elderly cohort of patients with end-stage renal failure starting haemodialysis in the United Kingdom.
Stephanie Stringer, Jyoti Baharani

Int Urol Nephrol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent advances in the pathogenesis and management of cast nephropathy (myeloma kidney).
Stephanie Stringer, Kolitha Basnayake, Colin Hutchison, Paul Cockwell

Bone Marrow Res· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The biology of immunoglobulin free light chains and kidney injury.
Kolitha Basnayake, Stephanie J Stringer, Colin A Hutchison, Paul Cockwell

Kidney Int· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early reduction of serum-free light chains associates with renal recovery in myeloma kidney.
Colin A Hutchison, Paul Cockwell, Stephanie Stringer, Arthur Bradwell, Mark Cook

J Am Soc Nephrol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aggregated serum free light chains may prevent adequate removal by high cut-off haemodialysis.
Stephen Harding, Francois Provot, Jean-Baptise Beuscart, Mark Cook, Arthur R Bradwell, Stephanie Stringer

Nephrol Dial Transplant· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical antitumor activity and pharmacokinetics of methyl-2-benzimidazolecarbamate (FB642).
Desirée Hao, Jinee D Rizzo, Stephanie Stringer, Rodney V Moore, Jennifer Marty

Invest New Drugs· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis